Company Description
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL’s operating model for its two businesses, CSL Behring and Seqirus.
CSL Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.csl.com.au.
This is a large cap company with market cap of 115263 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
while Company PB is greater than both sector and market. On the other hand,
| Earnings | PE | PB | PE growth | |
|---|---|---|---|---|
| Company | 1.7 | 38.4 | 12.1 | 0 |
| Market | 1.03 | 20.6 | 1.71 | 1.15 |
| Sector | 1.7 | 39.6 | 5.78 | 0.26 |
Dividend Growth Chart
The following chart shows you how csl dividend grows in the recent years.CSL Limited has dividend yield of 1.12%